High-throughput drug screening in advanced pre-clinical 3D melanoma models identifies potential first-line therapies for NRAS-mutated melanomaCristian Angeli, Stephanie Kreis|Journal of Experimental & Clinical Cancer Research|2025Cited by 5
High-throughput drug screening in advanced pre-clinical 3D melanoma models identifies potential first-line therapies for NRAS-mutated melanomaCristian Angeli, Stephanie Kreis|Research Square|2025Cited by 0